1. Home
  2. ATNF

ATNF

180 Life Sciences Corp.

Logo 180 Life Sciences Corp.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

Founded: 2016 Country:
United States
United States
Employees: N/A City: PALO ALTO
Market Cap: 2.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 92.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -52.59 EPS Growth: N/A
52 Week Low/High: $1.80 - $27.93 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 54.15%

Share on Social Networks: